EXVIV Start free →

EXVIV evidence profile

Sim

https://sim.ai

Review verified moves first. Open the official source or before-and-after evidence when you need the full record.

Public proof receipts

The useful part, first.

These are delayed P0 and P1 receipts from the curated public set. Same-day coverage and the rest of the watchlist stay in a private workspace.

P1integration

The release includes a new library article on using a Postgres MCP Server with AI Agents, covering security, deployment, and evaluation.

BEFORE

v0.9.2

AFTER

v0.9.12

View evidence

Version 0.9.12 adds capabilities to compare fork deployments, integrate You.com, browse Lucid and Notion content, and execute Power BI actions. The release includes a new library article on using a Postgres MCP Server with AI Agents, covering security, deployment, and evaluation.

WHY IT MAY MATTER

An ecosystem expansion can add distribution, increase switching costs, or close an adoption gap.

P1feature

A product capability changed.

BEFORE

helm-chart-1.11.4

AFTER

v0.9.10

View evidence

Version 0.9.10 introduces capabilities to compare deployment versions, render diff fences and mermaid diagrams, embed live dashboard panels, and cycle composer modes.

WHY IT MAY MATTER

A new release or deprecation can change feature parity, migration risk, and the next competitive response.

P1packaging

Version 0.9.6 introduces an opt-in fork sync feature for new workflows.

BEFORE

v0.8.55

AFTER

v0.9.6

View evidence

Version 0.9.6 introduces an opt-in fork sync feature for new workflows. The search system now accepts several same-kind native queries per account and caps oversized read limits.

WHY IT MAY MATTER

An ecosystem expansion can add distribution, increase switching costs, or close an adoption gap.

Monitored sources

Audit the watchlist.

AI Workflow Automation · launch · feature · positioning · pricing

4 monitored pagesView source list

Put this company in context.

Compare source depth and reviewed evidence across nearby ai workflow automation companies.

Open Evidence Compare →